PB2092: INCIDENCE AND RISK FACTORS ASSOCIATED WITH BLEEDING FOLLOWING ANTI-B CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

• Turab Mohammed,
• Moazzam Shahzad,
• Lauren Peres,
• Sushmita Khadka,
• Christelle Colinleitzinger,
• Abida Babu,
• William Doyle,
• Omar Castaneda Puglianini,
• Laura Oswald,
• Gabe De Avila,
• Ariel Grajales-Cruz,
• Brandon Blue,
• Jose Ochoa-Bayona,
• Eric Smith,
• Salvatore Corallo,
• Farhad Khimani4,
• Rawan Faramand,
• Hany Elmariah,
• Aleksandr Lazaryan,
• Michael Jain,
• Hien Liu,
• Taiga Nishihori,
• Ken Shain,
• Rachid Baz,
• Melissa Alsina,
• Frederick Locke,
• Ciara Freeman,
• Doris Hansen

Affiliations

Turab Mohammed

1 Moffitt Cancer Center and Research Institute, Hematology - Oncology, Tampa, United States

Moazzam Shahzad

1 Moffitt Cancer Center and Research Institute, Hematology - Oncology, Tampa, United States

Lauren Peres

2 Moffitt Cancer Center and Research Institute, Department of Cancer Epidemiology, Tampa, United States

Sushmita Khadka

1 Moffitt Cancer Center and Research Institute, Hematology - Oncology, Tampa, United States

Christelle Colinleitzinger

2 Moffitt Cancer Center and Research Institute, Department of Cancer Epidemiology, Tampa, United States

Abida Babu

3 USF Health Morsani College of Medicine, Tampa, United States

William Doyle

3 USF Health Morsani College of Medicine, Tampa, United States

Omar Castaneda Puglianini

4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States

Laura Oswald

5 Moffitt Cancer Center and Research Institute, Department of Health Outcomes and Behavior, Tampa, United States

Gabe De Avila

4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States

Ariel Grajales-Cruz

6 Moffitt Cancer Center and Research Institute, Hematology, Myeloma Division, Tampa, United States

Brandon Blue

6 Moffitt Cancer Center and Research Institute, Hematology, Myeloma Division, Tampa, United States

Jose Ochoa-Bayona

4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States

Eric Smith

4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States

Salvatore Corallo

4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States

Farhad Khimani4

1 Moffitt Cancer Center and Research Institute, Hematology - Oncology, Tampa, United States

Rawan Faramand

4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States

Hany Elmariah

4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States

Aleksandr Lazaryan

4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States

Michael Jain

4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States

Hien Liu

4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States

Taiga Nishihori

4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States

Ken Shain

6 Moffitt Cancer Center and Research Institute, Hematology, Myeloma Division, Tampa, United States

Rachid Baz

7 Moffitt Cancer Center and Research Institute, Hematology, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States

Melissa Alsina

7 Moffitt Cancer Center and Research Institute, Hematology, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States

Frederick Locke

4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States

Ciara Freeman

4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States

Doris Hansen

4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States